Iovance Biotherapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell IOVA and other ETFs, options, and stocks.About IOVA
Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors.
IOVA Key Statistics
Stock Snapshot
The current Iovance Biotherapeutics(IOVA) stock price is $6.34, with a market capitalization of 4.07B. The stock trades at a price-to-earnings (P/E) ratio of -8.79.
As of 2026-08-08, Iovance Biotherapeutics(IOVA) stock has fluctuated between $5.88 and $6.92. The current price stands at $6.34, placing the stock +7.8% above today's low and -8.4% off the high.
Iovance Biotherapeutics(IOVA) shares are trading with a volume of 30.97M, against a daily average of 21.53M.
In the last year, Iovance Biotherapeutics(IOVA) shares hit a 52-week high of $6.92 and a 52-week low of $1.76.
In the last year, Iovance Biotherapeutics(IOVA) shares hit a 52-week high of $6.92 and a 52-week low of $1.76.
IOVA News
...
Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...
Iovance Biotherapeutics (IOVA) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more...
Analyst ratings
78%
of 9 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.